Sales Force Size: Down, Now Back Up
Executive Summary
Bristol-Myers Squibb's recent announcement that it was going to add 350 reps seems to be part of a quiet but nonetheless dramatic trend towards increasing the size of sales forces.
You may also be interested in...
Can You Hear That Whistle Blow? Sales Force Reductions Come with Risks
Pfizer's big sales force cuts mark the beginning of a disarmament in sales infrastructure across the pharmaceutical industry. That means a lot of sales reps will be out of work-and looking for payback.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Timely Acquisition Keeps Germany's Dermapharm Growing
With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm Arkopharma ensured Dermapharm recorded double-digit sales growth in 2023.